EVALUATION OF THE ROLE OF D-DIMER, FERRITIN PARAMETERS IN THE PROGNOSIS OF COVID-19 PATIENTS

Duy Pham Dinh; Tri Le Quang; Thu Tang Thi Mong; Nghia Nguyen Trong; Quang Nguyen Tho

doi:10.59354/ydth175.2024.267

Từ khóa:

COVID-19, SARS-CoV2, D-dimer, Ferritin

Tóm tắt

Background: COVID-19 has spread worldwide from December 2019 to the present. Many biological markers have been used to predict poor outcomes, contributing to early detection and improving patient management.

Objective: To evaluate the role of D-dimer and Ferritin parameters in predicting the severity of COVID-19 patients.

Methods: Cross-sectional descriptive design combined with a prospective study on 293 patients with positive RT-PCR results for SARS-CoV-2 at Military Hospital 7A; Demographic characteristics, vaccination history, underlying disease, and laboratory parameters including D-dimer and ferritin were collected. Patients were divided into two groups based on disease severity: mild group (n=208), and severe group (n=85).

Results: The median age of the study population was 49 (34-62), with 50.9% were male patients. The severe COVID-19 group had significantly higher ferritin and d-dimer levels compared to the mild COVID-19 group. ROC curve analysis, serum Ferritin concentration ≥ 602.5 Microg/L predicted severe COVID-19 with a sensitivity of 68.2% and specificity of 90.9%.

Conclusion: Early Ferritin analysis in COVID-19 patients could effectively predict the severity of the disease.

Tài liệu tham khảo

Petrilli, C.M., et al., Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. Bmj, 2020. 369: p. m1966.

Richardson, S., et al., Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama, 2020. 323(20): p. 2052-2059.

Chen, N., et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020. 395(10223): p. 507-513.

Joshi, S., et al., Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India. Emerg Infect Dis, 2022. 28(1): p. 1-8.

Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. International Journal of Infectious Diseases: IJID: official publication of the International Society for Infectious Diseases. Jun 2020;95:304-307. doi:10.1016/j. ijid.2020.04.061

Cheng L, Li H, Li L, et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. Oct 2020;34(10):e23618. doi:10.1002/jcla.23618

Zhou, F., et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020. 395(10229): p. 1054-1062.

Li, Y., et al., Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Lab Invest, 2020. 100(6): p. 794-800.